Biofusion

Research discovers how to target cell fusion; could lead to therapies, vaccines

Published in Gene Therapy Weekly, March 18th, 2004

Mayo Clinic cancer researchers have developed a way to biologically fuse living cells through the use of a genetically engineered cell membrane.

This process, which Mayo researchers call "biofusion," could speed development of new tumor treatments and cancer vaccines.

The Mayo Clinic cancer researchers' study on biofusion appears in the current issue of Nature Biotechnology. The researchers report their new process kills cancer tumor cells, based on their successful treatment of mice into which human cancers were implanted.

"Our biofusion research represents a promising new technological platform for enlisting natural...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2004-03-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry